185 related articles for article (PubMed ID: 27965321)
1. Suppressing P16
Wang W; Zhu Y; Huang K; Shan Y; Du J; Dong X; Ma P; Wu P; Zhang J; Huang W; Zhang T; Liao B; Yao D; Pan G; Liu J
FASEB J; 2017 Mar; 31(3):1130-1140. PubMed ID: 27965321
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.
Kranc KR; Bamforth SD; Bragança J; Norbury C; van Lohuizen M; Bhattacharya S
Mol Cell Biol; 2003 Nov; 23(21):7658-66. PubMed ID: 14560011
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16
Wang JL; Wu JH; Hong C; Wang YN; Zhou Y; Long ZW; Zhou Y; Qin HS
Pathol Res Pract; 2017 Dec; 213(12):1542-1551. PubMed ID: 29042141
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
5. A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1.
Negishi M; Saraya A; Mochizuki S; Helin K; Koseki H; Iwama A
PLoS One; 2010 Aug; 5(8):e12373. PubMed ID: 20808772
[TBL] [Abstract][Full Text] [Related]
6. Aberrations of the p14(ARF) and p16(INK4a) genes in renal cell carcinomas.
Kawada Y; Nakamura M; Ishida E; Shimada K; Oosterwijk E; Uemura H; Hirao Y; Chul KS; Konishi N
Jpn J Cancer Res; 2001 Dec; 92(12):1293-9. PubMed ID: 11749694
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.
Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF
J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
9. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
10. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines.
Park YB; Park MJ; Kimura K; Shimizu K; Lee SH; Yokota J
Cancer Genet Cytogenet; 2002 Mar; 133(2):105-11. PubMed ID: 11943335
[TBL] [Abstract][Full Text] [Related]
12. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
[TBL] [Abstract][Full Text] [Related]
13. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
[TBL] [Abstract][Full Text] [Related]
14. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
[TBL] [Abstract][Full Text] [Related]
15. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
[TBL] [Abstract][Full Text] [Related]
16. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
Xiong J; Epstein RJ
Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550
[TBL] [Abstract][Full Text] [Related]
18. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.
Bruggeman SW; Valk-Lingbeek ME; van der Stoop PP; Jacobs JJ; Kieboom K; Tanger E; Hulsman D; Leung C; Arsenijevic Y; Marino S; van Lohuizen M
Genes Dev; 2005 Jun; 19(12):1438-43. PubMed ID: 15964995
[TBL] [Abstract][Full Text] [Related]
19. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression.
Aguilo F; Zhou MM; Walsh MJ
Cancer Res; 2011 Aug; 71(16):5365-9. PubMed ID: 21828241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]